PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsHistone-arginine methyltransferase carm1
Histone-arginine methyltransferase carm1
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
5436 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeoplasmsD009369C801728728454309
CarcinomaD002277C80.06111529419200
Prostatic neoplasmsD011471C61367921141162
Healthy volunteers/patients114105827158
Diabetes mellitusD003920EFO_0000400E08-E131322231973145
LeukemiaD007938C9551621437115
InfectionsD007239EFO_00005441530221729106
Hiv infectionsD015658EFO_0000764B202539131323104
Type 2 diabetes mellitusD003924EFO_0001360E111416221735103
Colorectal neoplasmsD01517930401412497
Show 374 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Breast neoplasmsD001943EFO_0003869C50571045451241
Lung neoplasmsD008175C34.9058823824174
Non-small-cell lung carcinomaD0022895983359163
LymphomaD008223C85.95355128107
AdenocarcinomaD00023016458665
Multiple myelomaD009101C90.033269664
Squamous cell carcinoma of head and neckD00007719516378758
Myeloid leukemia acuteD015470C92.025308556
Plasma cell neoplasmsD05421927209351
Head and neck neoplasmsD00625815275949
Show 365 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Neuroendocrine tumorsD018358EFO_1001901D3A.8512115
Biliary tract neoplasmsD001661C24.919111
Ischemic strokeD00008324211810
GliosarcomaD018316769
Weight gainD0154301189
Hearing lossD034381EFO_0004238H91.9279
Immunologic deficiency syndromesD007153D84.91628
Transitional cell carcinomaD002295458
EczemaD004485L30.92618
EnuresisD004775R32178
Show 396 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PharmacokineticsD0105991010
Drug interactionsD004347718
Diagnostic imagingD00395288
Cocaine-related disordersD019970F1466
Brain ischemiaD002545EFO_0003883I67.82246
Diabetic footD017719EFO_1001459156
Foot ulcerD016523156
Blood pressureD001794EFO_0004325156
Food diet and nutritionD000066888156
HypoglycemiaD007003E16.2325
Show 98 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
SleepD012890GO_003043188
AdenomaD00023677
Healthy dietD00007200177
Pediatric obesityD06376666
Medication adherenceD055118EFO_000634466
Child developmentD00265766
Surgical amputationD00067166
Gestational weight gainD00007806466
Postoperative complicationsD01118344
Spinal dysraphismD016135EFO_1001210Q0544
Show 526 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name
INN
Description
Classification
Unknown
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL ID
ChEBI ID
PubChem CID
DrugBank
UNII ID
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use